| Brenda Michelle Ormesher, MD | |
|
3377 Riverbend Dr, Springfield, OR 97477-8803 | |
| (541) 222-6345 | |
| Not Available |
| Full Name | Brenda Michelle Ormesher |
|---|---|
| Gender | Female |
| Speciality | Infectious Disease |
| Experience | 17 Years |
| Location | 3377 Riverbend Dr, Springfield, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922267384 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD157784 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
| Bay Area Hospital | Coos bay, OR | Hospital |
| Peace Harbor Medical Center | Florence, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Peacehealth | 8527016039 | 174 |
| Peacehealth Medical Group | 9032023270 | 206 |
News Archive
As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A quarter with record sales concluded a year that set the stage for an increased potential in growth.
Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.
› Verified 3 days ago
| Entity Name | Peacehealth Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447207287 PECOS PAC ID: 9032023270 Enrollment ID: O20031113000097 |
News Archive
As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A quarter with record sales concluded a year that set the stage for an increased potential in growth.
Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.
› Verified 3 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982774378 PECOS PAC ID: 4587573001 Enrollment ID: O20031215000598 |
News Archive
As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A quarter with record sales concluded a year that set the stage for an increased potential in growth.
Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.
› Verified 3 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740223874 PECOS PAC ID: 8527016039 Enrollment ID: O20050111000353 |
News Archive
As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A quarter with record sales concluded a year that set the stage for an increased potential in growth.
Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Michelle Ormesher, MD Po Box 24410, Eugene, OR 97402-0451 Ph: () - | Brenda Michelle Ormesher, MD 3377 Riverbend Dr, Springfield, OR 97477-8803 Ph: (541) 222-6345 |
News Archive
As a benchmark for diagnosing diabetes, the importance of the A1C test must be reevaluated to improve glycemic numeracy of policy makers, patients and providers – who must make real-world decisions. This is based on a commentary published by Wiley-Blackwell in the Journal of Diabetes.
Patients with postoperative recurrent non-small-cell lung cancer harbouring epidermal growth factor receptor mutations have longer progression-free and overall survival with gefitinib treatment, than those with stage IV disease, Japanese researchers report.
A quarter with record sales concluded a year that set the stage for an increased potential in growth.
Going back in time to compare evolutionary changes in several thousand generations of E. coli, a University of Houston biologist hopes to one day be able to isolate a bacterial pathogen and predict the likelihood it will become resistant to a particular antibiotic.
› Verified 3 days ago
Yiyakchu Jung Thapa, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Dr. Luis Eduardo Leyton-gonzalez, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Donald K Yang, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3355 Riverbend Dr, Suite 500, Springfield, OR 97477 Phone: 541-868-9500 Fax: 541-685-5920 | |
Dr. Peter A Kovach, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-683-5001 | |
Satyam Lakshmanbhai Patel, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3377 Riverbend Dr, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 | |
Priya Joseph Carden, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2073 Olympic Street, Springfield, OR 97477 Phone: 541-682-3550 Fax: 541-682-6703 | |
Jaswinder Kaur Singh, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Peacehealth Hospital Medicine, 3377 Riverbend Drive, Springfield, OR 97477 Phone: 541-222-6389 Fax: 541-222-6385 |